Find trending articles through Social News Discovery®! Providing a collaboration of news through social media technologies.
Follow your friends and create your own Online Social Newspaper! Invite your friends to follow you from Facebook. Filter the news articles you see by section, clipper, or mood. Rate each article and comment on all news clips!
Receive site and email notifications about comments and news clips that you are collaborating on!
Get the latest news on the Everyone page, the viral and trending news clips will always be at the top! See the trending news and articles!
"THE BUSINESS TIMES Consumer - [LONDON] Sanofi said it's ready to act swiftly to reach a deal with US biotechnology company Medivation Inc as profit and sales declined, highlighting the need for new medicines to propel growth.. Read more at The Business Times.", www.businesstimes.com.sg
"Big Pharma player Sanofi has changed its top leader but CEO Olivier Brandicourt has been unable to keep the drugmaker’s trajectory from heading down. Sanofi is hoping that its proposed buyout of Medivation will tilt the numbers back up, but first it has to get the deal done.", www.fiercepharma.com
"After months and months of seeing its advances spurned by Medivation, Sanofi has spent the past few weeks working toward a potential deal under a confidentiality agreement with its target. From this new, potentially-less-adversarial negotiating position, Sanofi says it is ready to move quickly to get a deal done.", www.fiercebiotech.com
"Reports suggest that Gilead Sciences (GILD) and Celgene (CELG) have joined the bidding process for Medviation (MDVN), one that already includes (maybe) Amgen (AMGN), and of course Sanofi (SNY), which is trying to throw out Medivation's board. Of the three biotech giant's, Citigroup's Robyn Karnauskas and team argue that Amgen is best positioned to win the battle. They explain why:", blogs.barrons.com
"Alnylam Pharmaceuticals Inc. rose as much as 12 percent, the most in more than a year, after Sanofi, which owns a stake in the company, accelerated its pursuit of another drugmaker as potential rivals circled, suggesting demand for biotechnology acquisitions may be picking up.", www.bloomberg.com
"NEW YORK (AP) — French drug company Sanofi is trying to toss the entire board at Medivation after the U.S. drugmaker rejected its $9.3 billion takeover bid. Sanofi's board nominees include former Arch Chemicals CEO Michael Campbell and Barbara Deptula, a former executive at Irish eye drugmaker Shire.", www.seattlepi.com
Please enjoy the site during our beta phase and provide us with feedback on suggestions and issue details. Please remember that we are still in beta and there will be issues and site changes during this time.
Newsclip® the leading Online Social Newspaper, find trending articles through Social News Discovery®!
You can reopen the "Getting Started Tutorial" dialog from within the About menu in the top right corner.